Please enable JavaScript to continue using this application.

Compare $BNTC vs $CYPH | Chartloom

Compare

$BNTC vs $CYPH

Benitec Biopharma Inc · Cypherpunk Technologies Inc

BNTC

Benitec Biopharma Inc

CYPH

Cypherpunk Technologies Inc

Compare $BNTC vs $CYPH

Comparing Benitec Biopharma Inc and Cypherpunk Technologies Inc

BNTCBenitec Biopharma Inc

CYPHCypherpunk Technologies Inc

BNTCBenitec Biopharma Inc

Market cap

$305M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-37.1%

FCF yield

-5.5%

CYPHCypherpunk Technologies Inc

Market cap

$313M

P/E (TTM)

—

Forward P/E (NTM)

26.20x

Forward P/S (NTM)

6.06x

Rev growth (TTM)

—

YTD performance

160.2%

52W performance

292.0%

FCF yield

-11.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BNTC

CYPH

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

BNTC$305M

CYPH$313M

Enterprise Value

BNTC$125M

CYPH$305M

Price

BNTC$8.87

CYPH$2.94

P/E Ratio

BNTCN/A

CYPHN/A

P/S Ratio

BNTC4,474.96x

CYPH217.68x

EV/Sales

BNTC1,903.93x

CYPH0.00x

EV/EBITDA

BNTC0.00x

CYPH0.00x

P/B Ratio

BNTC1.77x

CYPH2.34x

P/FCF Ratio

BNTCN/A

CYPHN/A

EV/FCF

BNTC-7.50x

CYPH-8.83x

PEG Ratio

BNTCN/A

CYPHN/A

Forward P/E (NTM)

BNTCN/A

CYPH26.20x

Forward P/S (NTM)

BNTCN/A

CYPH6.06x

Revenue (TTM)

BNTC$0

CYPH$0

Revenue Growth (YoY)

BNTCN/A

CYPHN/A

Forward Rev Growth

BNTC13.8%

CYPH155.2%

Gross Margin (TTM)

BNTC100.0%

CYPH0.0%

Operating Margin (TTM)

BNTC0.0%

CYPH0.0%

EBITDA Margin (TTM)

BNTC0.0%

CYPH0.0%

Net Margin (TTM)

BNTC0.0%

CYPH0.0%

FCF Margin (TTM)

BNTCN/A

CYPHN/A

Net Income (TTM)

BNTC$-33M

CYPH$-877K

FCF (TTM)

BNTC$-17M

CYPH$-35M

EPS (TTM)

BNTC$0.00

CYPH-$0.00

ROE (TTM)

BNTC-3482.0%

CYPH-92.0%

ROA (TTM)

BNTC-3411.0%

CYPH-87.0%

ROIC (TTM)

BNTC-3482.0%

CYPH-92.0%

Cash

BNTC$180M

CYPH$8M

Debt

BNTC$0

CYPH$0

Net Cash/Debt

BNTC$180M

CYPH$8M

Current Ratio (TTM)

BNTC34.00x

CYPH79.19x

Quick Ratio (TTM)

BNTC33.70x

CYPH78.88x

Debt/Equity (TTM)

BNTC0.00x

CYPH0.00x

Debt/Assets (TTM)

BNTC0.0%

CYPH0.0%

Interest Coverage (TTM)

BNTCN/A

CYPHN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

CYPH0.00x

Beta

BNTC0.23

CYPH1.13

52W Performance

BNTC-37.1%

CYPH292.0%

YTD Performance

BNTC-29.5%

CYPH160.2%

% from 52W High

BNTC-47.1%

CYPH-29.8%

% from 52W Low

BNTC4.1%

CYPH648.1%

Asset Turnover (TTM)

BNTC0.01x

CYPH0.02x

FCF Yield (TTM)

BNTC-5.5%

CYPH-11.1%

Earnings Yield (TTM)

BNTC-10.7%

CYPH-0.3%

Dividend Yield (TTM)

BNTCN/A

CYPHN/A

Rule of 40

BNTC0.0

CYPH0.0

EV/GP/RG

BNTCN/A

CYPHN/A

Ticker research

View BNTC research View CYPH research

Metric	BNTC Benitec Biopharma Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$305M	$313M
Enterprise Value	$125M	$305M
Price	$8.87	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	217.68x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.77x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	N/A	6.06x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	155.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-877K
FCF (TTM)	$-17M	$-35M
EPS (TTM)	$0.00	-$0.00
ROE (TTM)	-3482.0%	-92.0%
ROA (TTM)	-3411.0%	-87.0%
ROIC (TTM)	-3482.0%	-92.0%
Financial Health
Cash	$180M	$8M
Debt	$0	$0
Net Cash/Debt	$180M	$8M
Current Ratio (TTM)	34.00x	79.19x
Quick Ratio (TTM)	33.70x	78.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.13
52W Performance	-37.1%	292.0%
YTD Performance	-29.5%	160.2%
% from 52W High	-47.1%	-29.8%
% from 52W Low	4.1%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-5.5%	-11.1%
Earnings Yield (TTM)	-10.7%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View CYPH research

Valuation

P/S Ratio

CYPH

217.68x

BNTC

4,474.96x

EV/FCF

CYPH

-8.83x

BNTC

-7.50x

Growth & revenue

Forward Revenue Growth

CYPH

155.2%

BNTC

13.8%

Profitability & performance

Gross Margin

BNTC

100.0%

CYPH

0.0%

ROE

CYPH

-92.0%

BNTC

-3482.0%

FCF Yield %

BNTC

-5.5%

CYPH

-11.1%

52-Week Performance

CYPH

292.0%

BNTC

-37.1%

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

BNTC$305M

CYPH$313M

Enterprise Value

BNTC$125M

CYPH$305M

Price

BNTC$8.87

CYPH$2.94

P/E Ratio

BNTCN/A

CYPHN/A

P/S Ratio

BNTC4,474.96x

CYPH217.68x

EV/Sales

BNTC1,903.93x

CYPH0.00x

EV/EBITDA

BNTC0.00x

CYPH0.00x

P/B Ratio

BNTC1.77x

CYPH2.34x

P/FCF Ratio

BNTCN/A

CYPHN/A

EV/FCF

BNTC-7.50x

CYPH-8.83x

PEG Ratio

BNTCN/A

CYPHN/A

Forward P/E (NTM)

BNTCN/A

CYPH26.20x

Forward P/S (NTM)

BNTCN/A

CYPH6.06x

Revenue (TTM)

BNTC$0

CYPH$0

Revenue Growth (YoY)

BNTCN/A

CYPHN/A

Forward Rev Growth

BNTC13.8%

CYPH155.2%

Gross Margin (TTM)

BNTC100.0%

CYPH0.0%

Operating Margin (TTM)

BNTC0.0%

CYPH0.0%

EBITDA Margin (TTM)

BNTC0.0%

CYPH0.0%

Net Margin (TTM)

BNTC0.0%

CYPH0.0%

FCF Margin (TTM)

BNTCN/A

CYPHN/A

Net Income (TTM)

BNTC$-33M

CYPH$-877K

FCF (TTM)

BNTC$-17M

CYPH$-35M

EPS (TTM)

BNTC$0.00

CYPH-$0.00

ROE (TTM)

BNTC-3482.0%

CYPH-92.0%

ROA (TTM)

BNTC-3411.0%

CYPH-87.0%

ROIC (TTM)

BNTC-3482.0%

CYPH-92.0%

Cash

BNTC$180M

CYPH$8M

Debt

BNTC$0

CYPH$0

Net Cash/Debt

BNTC$180M

CYPH$8M

Current Ratio (TTM)

BNTC34.00x

CYPH79.19x

Quick Ratio (TTM)

BNTC33.70x

CYPH78.88x

Debt/Equity (TTM)

BNTC0.00x

CYPH0.00x

Debt/Assets (TTM)

BNTC0.0%

CYPH0.0%

Interest Coverage (TTM)

BNTCN/A

CYPHN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

CYPH0.00x

Beta

BNTC0.23

CYPH1.13

52W Performance

BNTC-37.1%

CYPH292.0%

YTD Performance

BNTC-29.5%

CYPH160.2%

% from 52W High

BNTC-47.1%

CYPH-29.8%

% from 52W Low

BNTC4.1%

CYPH648.1%

Asset Turnover (TTM)

BNTC0.01x

CYPH0.02x

FCF Yield (TTM)

BNTC-5.5%

CYPH-11.1%

Earnings Yield (TTM)

BNTC-10.7%

CYPH-0.3%

Dividend Yield (TTM)

BNTCN/A

CYPHN/A

Rule of 40

BNTC0.0

CYPH0.0

EV/GP/RG

BNTCN/A

CYPHN/A

Ticker research

View BNTC research View CYPH research

Metric	BNTC Benitec Biopharma Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$305M	$313M
Enterprise Value	$125M	$305M
Price	$8.87	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	217.68x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.77x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	N/A	6.06x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	155.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-877K
FCF (TTM)	$-17M	$-35M
EPS (TTM)	$0.00	-$0.00
ROE (TTM)	-3482.0%	-92.0%
ROA (TTM)	-3411.0%	-87.0%
ROIC (TTM)	-3482.0%	-92.0%
Financial Health
Cash	$180M	$8M
Debt	$0	$0
Net Cash/Debt	$180M	$8M
Current Ratio (TTM)	34.00x	79.19x
Quick Ratio (TTM)	33.70x	78.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.13
52W Performance	-37.1%	292.0%
YTD Performance	-29.5%	160.2%
% from 52W High	-47.1%	-29.8%
% from 52W Low	4.1%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-5.5%	-11.1%
Earnings Yield (TTM)	-10.7%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View CYPH research